APA

Rodríguez-González F. G., Sieuwerts A. M., Smid M., Look M. P., Meijer-van Gelder M. E., de Weerd V., Sleijfer S., Martens J. W. M. & Foekens J. A. (20110801). MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. : Breast cancer research and treatment.

Chicago

Rodríguez-González F Germán, Sieuwerts Anieta M, Smid Marcel, Look Maxime P, Meijer-van Gelder Marion E, de Weerd Vanja, Sleijfer Stefan, Martens John W M and Foekens John A. 20110801. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. : Breast cancer research and treatment.

Harvard

Rodríguez-González F. G., Sieuwerts A. M., Smid M., Look M. P., Meijer-van Gelder M. E., de Weerd V., Sleijfer S., Martens J. W. M. and Foekens J. A. (20110801). MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. : Breast cancer research and treatment.

MLA

Rodríguez-González F Germán, Sieuwerts Anieta M, Smid Marcel, Look Maxime P, Meijer-van Gelder Marion E, de Weerd Vanja, Sleijfer Stefan, Martens John W M and Foekens John A. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer. : Breast cancer research and treatment. 20110801.